Ruchun JiPartner at Sidley Austin LLPSpeaker
Profile
Ruchun Ji focuses his practice on advising investors, strategic and private equity buyers, and high-growth companies in life sciences, healthcare, and technology industries globally. He counsels clients in a broad range of transactions, from company formation to venture capital financings, growth capital investments, joint ventures, strategic alliances, licensing and collaborations, mergers and acquisitions, initial public offerings, follow-ons and PIPEs. He also advises clients on regulatory matters involving the United States Committee on Foreign Investment in the United States (CFIUS) and disputes relating to licensing and collaboration transactions. Ruchun is recognized as a leading individual in Life Sciences (2025) and Private Equity: Buyouts & Venture Capital Investment (2023-2025) by Chambers Greater China Region and by Legal 500 Asia Pacific in Life Sciences and Healthcare (2023-2025), Corporate and M&A (2024), and Private Equity (2023).
Agenda Sessions
The Art of the Deal: NewCos and the Next Chapter of Biotech Strategy
, 10:35View Session